Inhibitors of mammalian melanocyte tyrosinase: In vitro comparisons of alkyl esters of gentisic acid with other putative inhibitors

Biochemical Pharmacology

Volumn 57, Issue 6, 1999, Pages 663-672

  Curto, Ernest V ^a   Kwong, Cecil ^a   Hermersdörfer, Heino ^b   Glatt, Hansruedi ^b   Santis, Chie ^c   Virador, Victoria ^c   Hearing Jr, Vincent J ^c   Dooley, Thomas P ^a  

^a SOUTHERN RESEARCH INSTITUTE   (United States)

^b GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Arbutin; Cosmeceutical; Hydroquinone; Kojic acid; Magnesium ascorbylphosphate; Melanogenesis; Methyl gentisate; Pigmentation; TRP 1; TRP 2

Indexed keywords

ARBUTIN; ASCORBIC ACID PHOSPHATE MAGNESIUM; DOPACHROME TAUTOMERASE; ENZYME INHIBITOR; GENTISIC ACID ESTER DERIVATIVE; GENTISIC ACID METHYL ESTER; HYDROQUINONE; KOJIC ACID; MONOPHENOL MONOOXYGENASE; OXIDOREDUCTASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME INHIBITION; IN VITRO STUDY; MELANOCYTE; MELANOGENESIS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CELL LINE; ENZYME INHIBITORS; ESTERS; GENTISATES; HYDROXYBENZOIC ACIDS; INTRAMOLECULAR OXIDOREDUCTASES; MELANINS; MELANOCYTES; MEMBRANE GLYCOPROTEINS; MICE; MONOPHENOL MONOOXYGENASE; MUTAGENICITY TESTS; OXIDOREDUCTASES; PROTEINS; SKIN PIGMENTATION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0033559796     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00340-2     Document Type: Article

References (31)

1. Hearing V.J. Jr. Monophenol monooxygenase (tyrosinase) Purification, properties, and reactions catalyzed . Methods Enzymol. 142:1987;154-165.
2. Spritz R.A., Hearing V.J. Genetic-disorders of pigmentation. Adv Hum Genet. 22:1994;1-45.
3. Frenk E. Treatment of melasma with depigmenting agents. Melasma New Approaches to Treatment . 1995;9-15 Martin Dunitz Ltd, London.
4. Dooley T.P. Is there room for a moderate level of regulatory oversight? Hori W., Drug Discovery Approaches for Developing Cosmeceuticals Advanced Skin Care and Cosmetic Products, Chap. 1.4 . 1997;International Business Communications, Southborough, MA.
5. Dooley T.P. Topical skin depigmentation agents Current products and discovery of novel inhibitors of melanogenesis . J Dermatol Treat. 8:1997;275-279.
6. Dooley T.P., Gadwood R.C., Kilgore K., Thomasco L.M. Development of an in vitro primary screen for skin depigmentation and antimelanoma agents. Skin Pharmacol. 7:1994;188-200.
7. An Abridgment of The New Funk & Wagnalls Encyclopedia. Morse J.L., The Universal Standard Encyclopedia, Vol, 10. 1955;3662-36630 Unicorn, New York.
8. th Edn, Abstract No. 4290, p. 688. Merck & Co., Rahway, NJ, 1989.
9. J-Hua L., Smith P.C. Direct analysis of salicylic acid, salicyl acyl glucuronide, salicyluric acid and gentisic acid in human plasma and urine by high-performance liquid chromatography. J Chromatogr [B]. 675:1996;61-70.
10. Glatt H.R., Padykula R., Berchtold G.A., Ludewig G., Platt K.-L., Klein J., Oesch F. Multiple activation pathways of benzene leading to products with varying genotoxic characteristics. Environ Health Perspect. 82:1989;81-89.
11. Glatt H.R. Endogenous mutagens derived from amino acids. Mutat Res. 238:1990;235-243.
12. La Du B.N. Alcaptonuria and ochronotic arthritis. Mol Biol Med. 8:1991;31-38.
13. Physica, © 1993-1997, Chuma JL, TRIUMF, 4004 Wesbrook Mall, Vancouver, BC, Canada V6T 2A3.
14. Bennett D.C., Cooper P.J., Hart I.R. A line of non-tumorigenic mouse melanocytes, syngeneic with B16 melanoma and requiring a tumor promoter for growth. Int J Cancer. 39:1987;414-418.
15. Adachi K., Halprin K.M. A sensitive fluorometric assay method for mammalian tyrosinase. Biochem Biophys Res Commun. 26:1967;241-246.
16. Tsukamoto K., Jackson I.J., Urabe K., Montague P.M., Hearing V.J. A second tyrosinase-related protein, TRP2, is a melanogenic enzyme termed DOPAchrome tautomerase. EMBO J. 11:1992;519-526.
17. Korner A.M., Pawelek J.M. DOPAchrome conversion, a possible control point in melanin biosynthesis. J Invest Dermatol. 75:1980;192-195.
18. Kobayashi T., Urabe K., Winder A.J., Jimenez-Cervantes C., Imokawa G., Brewington T., Solano F., Garcia-Borron J.C., Hearing V.J. Tyrosinase related protein 1 (TRP1) functions as a DHICA oxidase in melanin biosynthesis. EMBO J. 13:1994;5818-5825.
19. Glatt H., Piée A., Pauly K., Steinbrecher T., Schrode R., Oesch F., Seidel A. Fjord- and bay-region diol-epoxides investigated for stability, SOS induction in Escherichia coli, and mutagenicity in Salmonella typhimurium and mammalian cells. Cancer Res. 51:1991;1659-1667.
20. Glatt H.R., Oesch F. Activation of N-acetoxy- and N-hydroxy-2-acetylaminofluorene to mutagenic and cytotoxic metabolites by V79 Chinese hamster cells. Mutat Res. 149:1985;265-269.
21. Hermersdörfer H., Ozierenski B., Schmalix W.A., Doehmer J., Glatt H.R. Cell culture system for the controlled intracellular generation of reactive oxygen species. Toxicol In Vitro. 11:1997;569-572.
22. Smith C.J., O'Hare K.B., Allen J.C. Selective cytotoxicity of hydroquinone for melanocyte-derived cells is mediated by tyrosinase activity but independent of melanin content. Pigment Cell Res. 1:1988;386-389.
23. Maeda K., Fukuda M. Arbutin Mechanism of its depigmentation actions in human melanocyte culture . J Pharmacol Exp Ther. 267:1995;765-769.
24. Cabanes J., Chazarra S., Garcia-Carmona F. Kojic acid, a cosmetic skin whitening agent, is a slow-binding inhibitor of catecholase activity of tyrosinase. J Pharm Pharmacol. 46:1994;982-985.
25. Kameyama K., Sakai C., Kondoh S., Yonemoto K., Nishiyam S., Tagawa M., Murata T., Ohnuma T., Quigley J., Dorsky A., Bucks D., Blanock K. Inhibitory effect of magnesium L-ascorbyl-2-phosphate (VC-PMG) on melanogenesis in vitro and in vivo. J Am Acad Dermatol. 34:1996;29-33.
26. National Toxicology Program Technical Report Series No. 366, Toxicology and Carcinogenesis Studies of Hydroquinone (CAS No. 123-31-9) in F344/N Rats and B6C3F1 Mice. National Technical Information Service, U.S. Department of Commerce, Springfield, VA, 1989.
27. Kubowitz F. Cleavage and resynthesis of polyphenoloxidase and hemocyanin. Biochem Z. 299:1938;32-57.
28. Yasunobu K.T. Mode of action of tyrosinase. Gordon M., Pigment Cell Biology. 1959;583-608 Academic Press, New York.
29. Lerch K. Protein and active-site structure of tyrosinase. Bagnara J.T., Advances in Pigment Cell Research. 1988;85-98 Alan R. Liss, New York.
30. Maddaluno J.F., Faull K.F. Inhibition of mushroom tyrosinase by 3-amino-L-tyrosine Molecular probing of the active site of the enzyme . Experientia. 44:1988;885-887.
31. Spritz R.A., Ho L., Furumura M., Hearing V.J. Mutational analysis of copper binding by human tyrosinase. J Invest Dermatol. 109:1997;207-212.